Home
Subscription
October 2024 issue
September 2024 issue
August 2024 issue
July 2024 issue
June 2024 issue
May 2024 issue
April 2024 issue
April 1, 2024 issue
March 2024 issue
February 2024 issue
January 2024 issue
BACK ISSUES
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2010 Issues
December 2010 Issue
• Appreciation and Anticipation
• New Therapeutic Agents Marketed in the United States in 2010
• Index for 2006 – 2010
November 2010 Issue
• Feature - Strike 3 – CVS Should be OUT!
• New Drug Review: Dabigatran etexilate mesylate (Pradaxa)
October 2010 Issue
• Feature - Prescription Benefit Programs – Pharmacy Needs Greater Strength and New Strategies!
• New Drug Review: Polidocanol (Asclera)
September 2010 Issue
• Feature - CARE is Missing in Health Insurance Reform! Independent Pharmacists are Well Positioned to Provide It!
• New Drug Review: Dienogest/estradiol valerate (Natazia)
August 2010 Issue
• Feature - Who are Pharmacy's Leaders?
• New Drug Review: Tocilizumab (Actemra)
July 2010 Issue
• Feature - We Have TOO MANY Colleges of Pharmacy!
• New Drug Review: Denosumab (Prolia)
June 2010 Issue
• Feature - CVS Caremark's Participation in Medicare Prescription Programs should be Terminated!
• New Drug Review: Pitavastatin calcium (Livalo)
May 2010 Issue
• Feature - Herb Denenberg – The Ultimate Activist and a Great Friend of Pharmacy
• New Drug Review: Dalfampridine (Ampyra)
April 2010 Issue
• Feature - Pharmacy Must Develop Opportunities Now! (Before Health Insurance "Reform" Limits our Role)
• New Drug Review: Liraglutide (Victoza)
March 2010 Issue
• Feature - Tobacco Sales in Pharmacies – A Historic Decision by APhA Delegates
• New Drug Review: Ustekinumab (Stelara)
February 2010 Issue
• Feature - Dispensing Error – And a Pharmacist in Prison
• New Drug Review: Iloperidone (Fanapt)
January 2010 Issue
• Feature - Health Care Reform – Let's Start Over and Do It Right!
• New Drug Review: Asenapine (Saphris)
| |
